The QualityStocks Daily Monday, October 1st, 2018

Today's Top 3 StockMarketWatch

QualityStocks (MOMT) +71.43%

Schaeffer's (NBEV) +67.29%

StockMarketWatch (LEVB) +65.01%

The QualityStocks Daily Stock List

NewBridge Global Ventures, Inc. (NBGV)

Stockflare, Penny Stock Hub, OTC Stock Picks, Central Charts, Wallet Investor, GuruFocus, MarketWatch, OTC Markets, Stockhouse, Simply Wall St, 4-Traders, Morningstar, Infront Analytics, Spotlight Growth, Investors Hangout, and Dividend Investor reported on NewBridge Global Ventures, Inc. (NBGV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NewBridge Global Ventures, Inc. focuses on the developing legal and regulated cannabis industry. It provides business consulting services to companies operating within the legal medical cannabis and hemp related industries. The Company previously went by the name NABUfit Global, Inc. It changed its name to NewBridge Global Ventures, Inc. in December of 2017. The Company lists on the OTC Markets Group’s OTCQB. NewBridge Global Ventures is headquartered in Orem, Utah.

The Company engages in management consulting and control and non-control acquisitions in the legal cannabis sector and its different verticals. Its corporate mission centers on the worldwide education of healthcare professionals and institutions, global producers, processors, and distributors, and ancillary/supporting technologies, which can impact the international healthcare and wellness industries.

NewBridge Global Ventures’ portfolio "eco-system" consists of education, production and distribution companies. Its portfolio includes Elevated Education (EE). EE provides continuing education for physicians and healthcare professionals who need to learn about medical marijuana and other emerging healthcare trends including treatment of opioid dependency, and more.

Another portfolio company is Pure Life Distributors. Pure Life (based in Puerto Rico) is pursuing term sheets in place with a well-known hemp oil company for distributing CBD products throughout Puerto Rico.

Last week, NewBridge Global Ventures announced that its wholly-owned subsidiary, Elevated Education (EE) completed post-production processing of its first proprietary education module for distribution on a commercial basis. The module is entitled “The Endocannabinoid System”. The module is an introductory technical program. It was produced to provide a foundational understanding for healthcare professionals of phytocannabinoids and their interaction with the Endocannabinoid System.

Today, NewBridge Global Ventures announced that it entered into definitive agreements to acquire all of the issued and outstanding ownership interests of six privately-held companies operating in the cannabis industry via the issuance of 31 million shares of common stock. Under the definitive documents, NewBridge Global Ventures will acquire 100 percent of the six Companies that focus on genetics, cultivation, extraction, as well as distribution. The six Companies are Roots Nursery, LLC; 5Leaf, LLC; GLML, LLC; Mad Creek Farm, LLC; 11thSt., LLC; and Timothy, LLC.

NewBridge Global Ventures, Inc. (NBGV), closed Monday's trading session at $2.18, up 9.00%, on 9,219 volume with 17 trades. The average volume for the last 3 months is 5,909 and the stock's 52-week low/high is $0.25/$6.01.

chart

Gold Reserve, Inc. (GDRZF)

Stockhouse, OTC Markets, 4-Traders, The Street, MarketWatch, Equities, InvestorsHub, and Super Stock Screener reported on Gold Reserve, Inc. (GDRZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gold Reserve, Inc. acquires, explores, and develops mining projects. It has a history in mining dating back to 1956 and formed for the purpose of acquiring, exploring, and developing mining properties and placing them into production. An exploration stage company, Gold Reserve is based in Spokane, Washington. The Company lists on the OTC Markets’ OTCQX.

Gold Reserve was thoroughly pursuing its arbitration claim against the Bolivarian Republic of Venezuela. It was doing so while continuing to pursue other opportunities. Its objective is to successfully develop proven and probable reserves through making selective property and/or corporate acquisitions.

In 1992, Gold Reserve acquired and began developing what is now known as the Brisas gold and copper project, located in the historic Km 88 mining district of the State of Bolivar in southeastern Venezuela. The Brisas deposit contains ore reserves of 10.2 million ounces of gold and 1.4 billion pounds of copper. Gold Reserve invested close to US $300 million in acquisition, land exploration, development, equipment, and engineering costs from 1992 to 2009.

In April 2008, after Gold Reserve successfully developed the Brisas Project to the point of construction, Venezuela arbitrarily revoked the previous authorization to go ahead with construction of the Brisas Project, eliminating Gold Reserve’s ability to exploit the Brisas Project.

Gold Reserve executed an agreement (Mixed Company Agreement) with Venezuela in August of 2016 for the creation of a jointly owned company (Mixed Company). In October of 2016, together with Venezuela, it established Empresa Mixta Ecosocialista Siembra Minera, S.A., the entity whose mission is to develop the Brisas Cristinas Project.

Gold Reserve signed a settlement agreement (as amended) in June of 2017 with Venezuela that contemplated payment of the Award (including interest) and the purchase of its Mining Data by Venezuela (Settlement Agreement).

With this Agreement, Venezuela agreed to pay Gold Reserve $792 million to satisfy the Award and $240 million for the Mining Data for a total of roughly $1.032 billion. Moreover, Venezuela irrevocably waived its right to pursue any further annulment proceedings associated with Gold Reserve’s enforcement of the Award.

Gold Reserve completed, on March 1, 2016, the acquisition of certain wholly-owned mining claims called the LMS Gold Project (LMS Property), together with certain personal property for $350,000, pursuant to a Purchase and Sale Agreement with Raven Gold Alaska, Inc., a wholly-owned subsidiary of Corvus Gold, Inc. The LMS Property remains at an early stage of exploration. It is not material to Gold Reserve.

This past March, Gold Reserve provided the results of a Preliminary Economic Assessment (PEA) of the Siembra Minera Gold Copper Project in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101).

Gold Reserve President, Mr. Doug Belanger, said in March, "This study confirms that the Siembra Minera Project is one of the largest gold-copper deposits in the world with some of the lowest project operating costs for such a large project."

Recently, Gold Reserve announced that the mixed company Empresa Mixta Ecosocialista Siembra Minera S.A. (SM), owned 45 percent by Gold Reserve and 55 percent by the Bolivarian Republic of Venezuela, received the Permit to Effect for the Siembra Minera Gold Copper Project (SM Project) from the Venezuelan Ministry of the Environment.

The Permit to Effect will permit site clearing, construction of a temporary camp and warehouse facilities, drilling of dewatering and development drill holes, construction of access roads on the property, and opening of the quarry for construction aggregates.

Gold Reserve, Inc. (GDRZF), closed Monday's trading session at $2.598, up 6.04%, on 8,016 volume with 8 trades. The average volume for the last 3 months is 14,673 and the stock's 52-week low/high is $2.05/$4.25.

chart

Ipsidy, Inc. (IDTY)

Investors Hangout, InvestorsHub, Investopedia, TradingView, Proactive Investors, Barchart, Stockwatch, Simply Wall St, OTC Markets, Stockhouse, 4-Traders, and Penny Stock Hub reported on Ipsidy, Inc. (IDTY), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Ipsidy, Inc. is a provider of secure, biometric identification, identity management and electronic transaction processing services. The Company’s identity transaction platform creates a trusted transaction, embedding authenticated identity and event details with a digital signature and using a participant's mobile device to approve everyday transactions.

Established in 2009, Ipsidy is based in Long Beach, New York. The Company lists on the OTC Markets OTCQX. It formerly went by the name ID Global Solutions Corporation. It changed its name to Ipsidy, Inc. in February 2017.

The Company’s platform is undergoing design to use biometric and multi-factor identity management solutions intended to support a wide spectrum of electronic transactions. Ipsidy’s belief is that it is critical that businesses and consumers know who is on the other side of an electronic transaction and have an audit trail, proving that the identity of the other party was properly authenticated.

Ipsidy’s identity transaction platform aims to help its customers more rapidly and effectively secure their citizens, employees, customers and associated physical and digital transactions, and promote a more secure, globally connected world. The Company’s identity platform enables mobile users to more easily authenticate their identity to a mobile phone or portable device of their choosing.

Ipsidy has two operating subsidiaries: MultiPay in Colombia, (www.multipay.com.co); and Cards Plus in South Africa, (www.cardsplus.co.za).

In late June, Ipsidy and Skypatrol LLC announced that they agreed to offer SkyGuru. SkyGuru combines Skypatrol's GPS technology with Ipsidy's Transact digital issuance platform and mobile biometrics to deliver integrated cost-control and expense management to trucking fleet operators and logistics companies across the Latin American market. Skypatrol is a provider of unique GPS-tracking and fleet-management software tools.

SkyGuru is powered by Ipsidy's Transact digital issuance platform providing the Ipsidy Mobile Wallet. This wallet is a virtual payment account for mobile devices. The fleet's drivers download the Ipsidy Mobile Wallet. They subsequently proceed to make their purchases of fuel or other services at participating gas station and other merchants, to which Skypatrol's systems can specifically route them.

Ipsidy, Inc. (IDTY), closed Monday's trading session at $0.1825, down 3.95%, on 107,002 volume with 8 trades. The average volume for the last 3 months is 165,780 and the stock's 52-week low/high is $0.10/$0.365.

chart

Marina Biotech, Inc. (MRNA)

Stock Twits, MarketWatch, InvestorsHub, Amigo Bulls, The Street, MicroCap Daily, Street Insider, Barchart, YCharts, OTC Markets, Zacks, and Marketbeat reported on Marina Biotech, Inc. (MRNA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Marina Biotech, Inc. concentrates on the development and commercialization of unique therapeutics for hypertension, arthritis, pain, and oncology. The Company’s commercial product is Prestalia®. It is approved by the US FDA (Food and Drug Administration) for the treatment of hypertension. Prestalia® is being commercialized through the DyrctAxess platform. OTCQB-listed, Marina Biotech is based in City of Industry, California.

Marina Biotech is developing and commercializing late stage, non-addictive pain therapeutics. The Company’s mission is to provide effective and patient centric treatment for hypertension. This includes resistant hypertension.

Marina Biotech is working to create a universal platform for the effective treatment of hypertension and for the distribution of fixed dose combination [FDC] hypertensive drugs such as Prestalia® and those in its pipeline. Prestalia® contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker. Prestalia® is indicated for the treatment of hypertension, to lower blood pressure.

Prestalia® is available to physicians and patients via bpCareConnect. This is a hypertension management program offered by Symplmed. Prestalia® may be used in patients whose blood pressure is not adequately controlled on monotherapy. Prestalia® may be used as initial therapy in patients likely to require multiple drugs to realize blood pressure goals.

Additionally, Marina Biotech is developing and commercializing late stage, non-addictive pain therapeutics. The design of its ‘next-generation of celecoxib,’ including IT-102 and IT-103, are to control the dangerous side-effects of edema that prohibit the drug from being prescribed at higher doses. IT-102 and IT-103 are the Company’s next generation celecoxib for management of arthritis pain.

Last month, Marina Biotech announced that each of Uli Hacksell, Ph.D. and Robert C. Moscato, Jr. were appointed to serve as a member of its Board of Directors. Dr. Hacksell was also appointed to serve as Chairman of the Board. Dr. Hacksell has agreed to devote half of his business time to Marina Biotech. Mr. Moscato presently serves as the Chief Executive Officer of the Company. Each of the appointments was effective July 1, 2018.

Marina Biotech, Inc. (MRNA), closed Monday's trading session at $0.53, down 1.85%, on 24,025 volume with 23 trades. The average volume for the last 3 months is 7,154 and the stock's 52-week low/high is $0.43/$2.68.

chart

CurAegis Technologies, Inc. (CRGS)

Equity Clock, 4-Traders, InvestorsHub, Simply Wall St, and OTC Markets reported on CurAegis Technologies, Inc. (CRGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division. CurAegis is currently focusing on commercialization strategies in varied technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump.

CurAegis Technologies is headquartered in Rochester, New York. The Company lists on the OTC Markets Group’s OTCQB.

The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. The Company completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. It previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The CURA System consists of hardware and software that measures manifold metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information concerning their present and long-term sleep and fatigue health.

CurAegis Technologies’ Aegis hydraulic pump (Aegis Division) is a unique hydraulic design. Its objective is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.

The Z-Coach e-learning tool was acquired by CurAegis Technologies in September 2015. The first of six Z-Coach e-learning modules, Z-Coach Aviation, was designed for aviation professionals. If the CURA (Circadian User Risk Assessment) software detects an issue, Z-Coach creates a back-end solution needed to induce change and improve behavior. This program is broken down into two parts: Z-Coach Education and Z-Coach Intervention.

CurAegis Technologies’ plan is to license its technology to major manufacturers. The Company may consider an exclusive licensing agreement for a period of time if it believes that it is the best way to reach original equipment manufacturer (OEM) and after-market customers.

In May, CurAegis Technologies reported that it launched its CURA System designed for use with the FITBIT® Platform. The Company noted that its internal testing has been very positive. CurAegis has sold and shipped product. The Company is preparing to commence major pilots.

In addition, CurAegis has launched its business to business (B2B) sales programs. The Company stated that users will be able to purchase the FITBIT® via a link on its website or use their existing FITBIT®. CurAegis expects to introduce applications for the myCadian® and other watches for use with the CURA System in the near future.

CurAegis Technologies, Inc. (CRGS), closed Monday's trading session at $0.31, up 19.23%, on 27,300 volume with 10 trades. The average volume for the last 3 months is 17,053 and the stock's 52-week low/high is $0.10/$0.74.

chart

Golden Leaf Holdings Ltd. (GLDFF)

Stockhouse, Silicon Investor, Marketwired, InvestorX, InvestorsHub, MarketWatch, and Daily Marijuana Observer reported on Golden Leaf Holdings Ltd. (GLDFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Golden Leaf Holdings Ltd. is one of the largest cannabis oil and solution providers in North America. The Company is also a foremost cannabis enterprise in Oregon. Golden Leaf has expertise in extracting, refining, marketing, and selling cannabis oil. The Company is headquartered
 in Toronto, Ontario.

Golden Leaf is a leading cannabis products company built around recognized brands. It has operations in numerous jurisdictions including Oregon, Nevada and Canada. The Company cultivates, extracts, manufactures and distributes its products by way of its branded Chalice Farms retail dispensaries and through third party dispensaries.

Golden Leaf’s brands include Golden, Proper, Left Coast Connection, and Chalice Farms. Since opening in 2014, Chalice Farms has served the greater Portland, Oregon community with its chain of dispensaries selling its line of 12 premium edibles.

Golden Leaf has its Canadian subsidiary, Medical Marijuana Group (MMG).  MMG's genetic portfolio includes a strain that holds the highest CBD concentrations in Canada.

MMG was granted a cultivation license from Health Canada in November of 2017 for its state-of-the-art grow facility in the Province of Ontario. It began cultivation activities in early 2018. Since then, MMG has cultivated four complementary strains of cannabis, which span some of the most desired products in the medical and adult-use market. In early July, MMG harvested its first crops that had yields that were 30 percent more than originally forecasted.

Golden Leaf has its new edible product line of cannabis infused fruit chews. Golden is a Portland-based oils and extracts brand within the Golden Leaf portfolio. The new fruit chews feature a combination of premium cannabis oil, real fruit, and restorative ingredients.

Earlier this month, Golden Leaf announced the introduction of a number of cannabis concentrate product lines in Nevada via its wholly-owned subsidiary, Greenpoint Nevada. Greenpoint’s product launch includes its Golden Tinctures; its Golden Private Stash distillate vape cartridges; and its Golden CBD product lines using Golden Leaf’s best-in-class, cold ethanol extraction processes and proprietary blends of strain-specific terpenes. 

Via its Nevada operations, Golden Leaf products are now selling in more than half of the dispensaries in the State. The expectation is that market share will increase once Golden Leaf invests further in production infrastructure.

This week, Golden Leaf Holdings announced that it received, from the Oregon Liquor Control Commission, state licensure to operate its extraction facility in Portland, Oregon, effective July 19, 2018.

Mr. William Simpson, Golden Leaf Holdings’ Chief Executive Officer, said, “This facility will allow us to continue leveraging our experienced product development team to perform advanced research and development in cannabis extraction and allow us to introduce new and exciting products into the marketplace.”

Golden Leaf Holdings Ltd. (GLDFF), closed Monday's trading session at $0.223, up 8.04%, on 1,709,075 volume with 334 trades. The average volume for the last 3 months is 964,871 and the stock's 52-week low/high is $0.12/$0.58.

chart

Lithium Exploration Group, Inc. (LEXG)

MicroCap Daily, Insider Financial, Penny Stock Tweets, Epic Stock Picks, OTC Markets, and The Wolf of Penny Stocks reported on Lithium Exploration Group, Inc. (LEXG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lithium Exploration Group, Inc. concentrates on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. The Company is currently focusing on sales and distribution of the Sonic Cavitation Ltd. technology and the acquisition of oil and gas related assets in the U.S. and Canada. An exploration and development company, Lithium Exploration is based in Phoenix, Arizona.

Lithium Exploration’s commitment is to developing assets and technologies in Oil & Gas, and Waste Treatment. The Company is developing an ultrasonic generator for different field applications in the oil and gas industry. The technology provides lower cost, low energy solutions to many pre-existing processes within these markets.

Lithium Exploration’s Oil & Gas assets consist of the White Top Field. This asset is positioned onshore in Southwest Louisiana.  The cumulative production to-date is 32 million barrels. Current production is 120 barrels of oil per day.

The Company has partnered with Sonic Cavitation (SonCav) to develop SonCav's patented technology for the treatment of hydrocarbon fluid stocks and waste water. The SonCav generator is skid mounted for easy mobility to even the most remote field locations. At present, SonCav is field ready for customers across North America. SonCav runs off of 3 phase electricity. It produces no on-site emissions.

Lithium Exploration announced this past March that its partners in the White Top project were making major progress on the preparations to close on the eventual acquisition of the field and development strategy. The seismic data has been totally processed.

Lithium Exploration stated that it continues to impress all parties that have looked at it. The Company has a royalty interest in the future development of the major oil and gas opportunity in Louisiana.

Lithium Exploration’s Blockchain efforts in the oil and gas industry are moving forward. The Company has been incubating a Blockchain concept, which will make it much easier and more transparent for investors who are not part of the oil and gas ecosystem to participate in investment opportunities.

Nonetheless, the Company is not spending any money on those efforts until after the completion of the royalty acquisition.  Lithium Exploration is looking to partner with a couple of external companies to establish the Blockchain marketplace that it will manage.

This month, Lithium Exploration announced that preparation and permitting was initiated at its oil project in SW Louisiana. The expectation is that the pad undergoing preparation will host the drilling of the first three target locations.

A joint team of internal and external geophysicists have prepared the locations.  This team has identified these locations in a specific fault block, using the processed seismic data collected last year versus historical production from the field, and determined that these locations will be the most productive. The team has put a projection of 800K to 1.4M barrels of oil from this fault block that can be simultaneously extracted by drilling three wells at different depths. 

Lithium Exploration Group, Inc. (LEXG), closed Monday's trading session at $0.01091, up 3.41%, on 31,208 volume with 17 trades. The average volume for the last 3 months is 347,756 and the stock's 52-week low/high is $0.00855/$0.1349.

chart

Plateau Energy Metals, Inc. (PLUUF)

OTC Markets, Investors Hangout, MarketWatch, Barchart, Stockwatch, Investing News, Junior Mining Network, Stockhouse, Marketwired, and WatchDog Stocks reported on Plateau Energy Metals, Inc. (PLUUF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Plateau Energy Metals, Inc. is a uranium exploration and development company headquartered in Toronto, Ontario. The Company’s focus is on its properties on the Macusani Plateau in southeastern Peru. The Plateau is one of the largest, most highly prospective uranium districts in the world.  The Company is moving towards 2020 production.

Plateau Energy Metals controls all reported uranium resources known in Peru. Additionally, it controls substantial and growing lithium resources, and mineral concessions covering greater than 91,000 hectares (910 km2) situated close to significant infrastructure.

There is a history of mining in the area as well as premier infrastructure. Furthermore, the district has supportive government and local communities. Major exploration potential exists on the Macusani Plateau. Drilling is focused on less than 15 percent of the land package.

In June, Plateau Energy Metals announced that recent mapping/sampling efforts have expanded the Falchani lithium-rich mineralization an additional 1 km west of earlier announced sampling. The Company also announced continued strong results from three recently completed inclined diamond drill holes from Platform 3 and Platform 9 at the Falchani project. This project is situated in the Chaccaconiza area of Plateau’s Macusani Plateau Project in southeastern Peru.

This month, Plateau Energy Metals announced continued strong results from four recently completed vertical and one inclined diamond drill holes from Platform 10, Platform 25 and Platform 6, located up to 1 km north of earlier announced drilling and Platform 19A situated towards the southeastern edge of present drilling at the Falchani project, on its Macusani Plateau Project.

Mr. Ian Stalker, Plateau Energy Metals’ Executive Chairman and Interim Chief Executive Officer, said, “We now expect our maiden lithium mineral resource estimate for Falchani, to be finalized and reported early in this 3rd Quarter. It is important to note that the drilled area that will be covered in this initial Resource, will cover only +/- 25% of the known extent of the mapped lithium-rich tuff unit, and we therefore expect Falchani to grow much larger.”

Plateau Energy Metals, Inc. (PLUUF), closed Monday's trading session at $0.8532, up 6.65%, on 13,182 volume with 20 trades. The average volume for the last 3 months is 34,282 and the stock's 52-week low/high is $0.2129/$1.2699.

chart

PharmaCyte Biotech, Inc. (PMCB)

OTCJournal, PennyStockLaboratory, SmallCapNetwork, Cannabis Financial Network News, BUYINS.NET, MyBestStockAlerts, InvestorPlace, Goldman Small Cap Research, Damn Good Penny Picks, Penny Picks, Darth Trader, Wall Street Corner, Penny Stock General, PennyStockInformer, Fast Money Alerts, Penny Stock Beats, Stock Shock and Awe, The Stock Psycho, and Stock Market Media Group reported earlier on PharmaCyte Biotech, Inc. (PMCB), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

PharmaCyte Biotech, Inc. focuses on developing targeted treatments for cancer and diabetes applying its signature live cell encapsulation technology, Cell-in-a-Box®. This unique and patented technology is being utilized as a platform upon which treatments for many kinds of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. A clinical stage biotechnology company, PharmaCyte Biotech has its corporate headquarters in Silver Spring, Maryland.

The OTCQB-listed Company is also working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other kinds of solid cancerous tumors. PharmaCyte’s treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or "cancer-killing" form.

The capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. The live-cell encapsulation technology that the Company employs is a way to enclose living cells in protective “cocoons” roughly the size of the head of a pin. It encapsulates living cells, not drugs.

Each capsule can enclose about 10,000 cells. This number can differ depending upon the size of the cells encapsulated. PharmaCyte Biotech is advancing its new treatment for pancreatic cancer into the clinic in the United States, with study sites in Europe and Australia.

Additionally, the Company is developing treatments for cancer based upon chemical constituents of the Cannabis plant, named cannabinoids. It is studying ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects typically associated with cancer treatments.

In June, PharmaCyte Biotech announced that it successfully completed the comprehensive characterization of its proprietary cell clone known as 22P1G.

The 22P1G cells constitute the cells in the Master Cell Bank (MCB), which were prepared and tested by the Company’s contractor, Eurofins Lancaster Laboratories.

The cells from the MCB will serve as the active pharmaceutical ingredient (API) in PharmaCyte’s Cell-in-a Box® capsules, which will be used (together with low doses of the cancer prodrug ifosfamide) for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC) in the Company’s planned clinical trial.

Last week, PharmaCyte Biotech announced that it successfully completed a study on the stability after “hand thawing” syringes of the Cell-in-a-Box® encapsulated cells. The data obtained from this “hand thawing” study is compulsory by the U.S. Food and Drug Administration (FDA).

The results of the “hand thawing” study announced show that the viability of the cells remains essentially the same for a minimum of 30 minutes at room temperature. This serves to define the time that the interventional radiologist has to implant the Cell-in-a-Box® capsules after thawing to ensure cellular viability within the patient.

PharmaCyte Biotech, Inc. (PMCB), closed Monday's trading session at $0.06575, up 14.95%, on 7,741,439 volume with 438 trades. The average volume for the last 3 months is 1,500,611 and the stock's 52-week low/high is $0.0302/$0.1049.

chart

Accelerize, Inc. (ACLZ)

Buzz Stocks, Greenbackers, ResearchOTC, StockRockandRoll, Planet Penny Stocks, PennyStockProphet, StockOnion, FeedBlitz, Penny Pick Finders, StockOodles, and PennyStockLocks reported previously on Accelerize, Inc. (ACLZ), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Accelerize, Inc. provides marketing technology solutions that transform the way advertisers leverage their digital advertising data. CAKE is a division of Accelerize and is the Company’s digital marketing software division. CAKE provides a cloud-based solution to track and analyze the performance of digital marketing Return on Investment (ROI), in real-time. Accelerize has its corporate headquarters in Newport Beach, California.

CAKE is a software-as-a-service (SaaS) enterprise platform. It provides online tracking, reporting, lead distribution, and analytics solutions for advertisers, online marketers, affiliate marketers, and lead generators. With CAKE, one can track and optimize affiliate traffic. In addition, a user can collect, validate and distribute leads. Furthermore, one can gather and analyze multi-channel data.

Accelerize offers CAKE for Advertisers and CAKE for Networks. CAKE for Advertisers is a SaaS solution. It enables brand advertisers to unify the tracking, attribution, and optimization of digital marketing spend across search, display, email, video, social, affiliate, and other marketing channels.

CAKE for Networks is a marketing solution for affiliate networks. CAKE by Accelerize is headquartered in Newport Beach, with operations in New York, London, India, and Sydney, Australia.

Constructed on CAKE’s Marketing Intelligence platform, Journey is a cloud-based enterprise solution. Journey collects and analyzes customer journey data using multi-touch attribution for marketing campaign optimization.

Last month, Accelerize and its digital marketing software division CAKE announced major momentum in the Asia-Pacific (APAC) region. Revenue and Customer Growth increased by triple digit percentages over a two-year period.

Since establishing itself in important APAC markets in 2015, including India, China, Singapore, Indonesia, Australia and more, CAKE’s revenues in the region have increased by 322 percent, with a 283 percent increase in the number of APAC clients.

Santi Pierini, CAKE President and Chief Operating Officer of Accelerize, said, “International markets represented about 40 percent of our sales overall in 2017, and APAC continues to play an important role in CAKE’s ongoing growth strategy.”

Last week, Accelerize and CAKE announced its growing ecosystem of Connections, alliances with top digital media and marketing tools, which enrich customer journey insights for brands, agencies and publishers. Available to Journey by CAKE users, Connections enable digital marketers to easily extract data from media platforms. With this data, they can rapidly integrate it into a single platform - CAKE’s enterprise SaaS solution.

Accelerize, Inc. (ACLZ), closed Monday's trading session at $0.23, down 0.22%, on 12,100 volume with 3 trades. The average volume for the last 3 months is 10,466 and the stock's 52-week low/high is $0.2151/$0.40.

chart

AmpliTech Group, Inc. (AMPG)

Information Solutions Group, fusionspicks, Jet-Life Penny Stocks, OTCMagic, Ascending Stocks, Pumps and Dumps, HoleinOneStocks, HotStockProfits, Trading Wall St, Penny Stock Gainers, RockingPennyStocks, BestStocksDaily, Wallstreetbuzz, AllPennyStocks, SmallCapVoice, PennyStocks24, and Fortune Penny Stocks reported on AmpliTech Group, Inc. (AMPG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and global, SATCOM, Space, and Military markets. The Company also provides consulting services to help with any microwave components or systems design problems. AmpliTech Group is based in Bohemia, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

AmpliTech Group provides its customers with consulting services for their system development. It also provides technical assistance in integration and packaging technologies and microwave sub-systems and amplifier related sub-assemblies.

The Company’s designs cover the frequency spectrum from 50 kHz to 40 GHz - eventually providing designs up to 100 GHz. AmpliTech Group can provide complex, custom solutions for almost any custom requirements presented to it. It can provide contract assembly of customers' own designs.

AmpliTech uses the most up-to-date CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with first-rate accuracy. The Company expects to release new products targeted at the wireless and satellite markets that will provide advanced technology and performance.

AmpliTech Group announced last year that it entered into a Joint Venture (JV) Agreement with Trusted Networks, Inc. (TN). TN is a New York, New York based private company with facilities in Colorado Springs and Nashua, New Hampshire.

The focus of this JV is to develop an affordable mixed signal chipset that can be used at server/router level and also in mobile PDA applications to provide secure and encrypted communication with the objective of preventing hacking and cyber-attacks.

Recently, AmpliTech Group reported Q1 Revenue of $428,541 with a Net Profit of $42,770. This represents a 27 percent increase versus the same period last year. The Company stated that the overall “dip” last year was mainly attributed to a generally slow worldwide market for the RF/Microwave industry and to the dedication of more resources by AmpliTech Group to the expansion of marketing vistas and the development of new products.

AmpliTech Group, Inc. (AMPG), closed Monday's trading session at $0.0523, up 1.55%, on 250 volume with 1 trade. The average volume for the last 3 months is 69,437 and the stock's 52-week low/high is $0.0296/$0.3959.

chart

Greystone Logistics, Inc. (GLGI)

Zacks, Trading View, and MarketWatch reported on Greystone Logistics, Inc. (GLGI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Greystone Logistics, Inc. reprocesses and sells recycled plastic, and designs, manufactures, sells, and leases high-quality 100 percent recycled plastic pallets. These provide logistical solutions needed by a broad assortment of industries. These industries include food and beverage, agricultural, automotive, chemical, and pharmaceutical and consumer products. A "Green" manufacturing and leasing enterprise, Greystone Logistics has its corporate office in Tulsa, Oklahoma.

Greystone Logistics is the largest 100 percent recycled plastic pallet manufacturer in the U.S. The Company provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale.

Greystone Logistics technology, including that used in its injection molding equipment, and its proprietary blend of recycled plastic resins and patented pallet designs, enables speedy production of high-quality pallets and at lower costs than numerous processes. The recycled plastic for its pallets helps control material costs. This is while reducing environmental waste.

Greystone’s products include rackable, nestable, display, monoblock, and stackable pallets. Furthermore, the Company’s products include picture frame web-top pallets and web-top pallets. Greystone also sells recycled plastic that undergoes reprocessing into pellet form. It also provides pallet leasing services.

Greystone Logistics offers recycled pallets for sale including full picture frame and three skids models and IBC pallets. Plastic pallets last 10-50 times longer than wood; have residual (trade-in) value; are recyclable; have a high coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact; have substantially lower life cycle costs (cost per trip) and are suited for closed loop systems.

This past April, Greystone Logistics reported that Sales for the three months ended February 28, 2018 totaled $12,064,651 versus $8,693,851 for the prior period. This represents an increase of $3,370,800, or 39 percent.

Sales for the nine months ended February 28, 2018 were $32,073,828 versus $25,759,823 for the prior period. This represents an increase of $6,314,005, or 25 percent.

Net Income was $5,546 versus $920,883 for the three months ended February 28, 2018 and 2017, respectively, and $679,899 versus $1,133,317 for the nine months ended February 28, 2018 and 2017, respectively.

Greystone Logistics, Inc. (GLGI), closed Monday's trading session at $0.517, up 5.51%, on 9,500 volume with 2 trades. The average volume for the last 3 months is 39,452 and the stock's 52-week low/high is $0.378/$0.68.

chart

Manhattan Scientifics, Inc. (MHTX)

SmallCapVoice, Xtremepicks, The Penny Play, FeedBlitz, Hawk Associates, StockHotTips, BullRally, OurHotStockPicks, AllPennyStocks, and HotStockChat reported earlier on Manhattan Scientifics, Inc. (MHTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Manhattan Scientifics, Inc. concentrates on the commercialization of disruptive technologies in the nano-medicine space. The OTCQB-listed Company is currently developing commercial medical prosthetics applications for its ultra-fine grain metals. Its goal is to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, (now Imagion Biosystems), its wholly-owned subsidiary. Manhattan Scientifics is based in New York, New York. The Company has an office in Albuquerque, New Mexico, and Montreal, Quebec.

Manhattan Scientifics has expertise in licensing from the national laboratories (the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL)). Sandia National Laboratories is a multi-mission laboratory operated by National Technology and Engineering Solutions of Sandia LLC, a wholly-owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy’s National Nuclear Security Administration.

Manhattan Scientifics has an agreement to collaborate with The University of Texas M.D. Anderson Cancer Center (MDACC) to advance, demonstrate, and validate an innovative technology developed by Mr. Edward R. Flynn, PhD, for the very early detection of cancer. The Company has delivered its pioneering cancer measurement instrument to MDACC.

Manhattan Scientifics focuses on technology transfer and commercialization of transformative technologies in the nano medicine space. The Company creates Intellectual Property (IP) portfolios and business cases supporting new technologies. It guides them to relationships with industrial partners who are well-prepared to launch product.

The Company’s technology uses iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods. Currently, Manhattan Scientifics is centering on nanoparticle-based cancer detection via Senior Scientific. Moreover, it is focusing on nanostructured metals technology via wholly-owned subsidiary Metallicum, Inc.

Senior Scientific has formed a research collaboration with Weill Cornell Medicine. For this alliance, it will bring its magnetic relaxometry technology to Weill Cornell Medicine. Scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers.

Manhattan Scientifics is also working on the start of product trials on its cancer detection product. The nanostructured metals technology has been revenue producing for some years. The cancer detection technology can detect cancer years earlier.

Manhattan Scientifics started as a technology incubator. Early in its history, the Company worked on acquiring a number of technologies in the fields of holographic data storage, water purification, alternative energy, advanced computer haptics and currently, nanotechnology. The Company’s chief source of latent commercial technologies are the U.S. government laboratories in New Mexico.

Manhattan Scientifics, Inc. (MHTX), closed Monday's trading session at $0.0167, up 1.21%, on 46,762 volume with 8 trades. The average volume for the last 3 months is 144,795 and the stock's 52-week low/high is $0.011/$0.034.

chart

Pura Naturals, Inc. (PNAT)

OTC Markets, Marketwired, WhaleWisdon, YCharts, Stockwatch, Insider Financial, and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean through its innovative BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology that absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is headquartered Lake Forest, California.

The Company concentrates on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

Pura Naturals also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Company also has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner. The design of it is to cut through very greasy messes to leave behind only a citrus scent.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura’s household cleaning product delivers an innovative soap infusion. The pioneering foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

The Company’s Pura Marine division centers on developing solutions utilzing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors.

Pura Naturals has launched a new line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils. The expectation is that the line will include facial slices, body bars, soap infused sponges and other custom products.

The Company also has its new partnership with Ms. Noreen Taylor, celebrity make-up artist and Chief Executive Officer (CEO) of Donore by The Organic Face. Together, Pura Naturals and Ms. Taylor will launch a new skincare, body care and cosmetics line. This line will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.

Mr. Robert Doherty, Pura Naturals’ CEO, said, “Noreen is the CEO of Donore by The Organic Face, a company dedicated to creating non-toxic wholesome organic beauty products. The mission of Donore perfectly aligns with that of Pura which inspired our collaboration on an organic health and beauty care line infused with CBD oil.”

Pura Naturals, Inc. (PNAT), closed Monday's trading session at $0.0105, up 12.90%, on 27,954,746 volume with 480 trades. The average volume for the last 3 months is 12,264,395 and the stock's 52-week low/high is $0.0032/$0.36.

chart

The QualityStocks Company Corner

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or "the Company"), a leading online financial information provider for Chinese investors, announces plans to launch CBD Hemp Wine, its private brand, hemp-infused, rice wine, through its wholly-owned foreign enterprise CBD Biotechnology Co. Ltd ("CBD Biotech"). Given the popularity of infused wine and liquor in recent years, CBD Biotech's new hemp-infused, rice wine was developed with the hemp enthusiast in mind.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.8049, up 24.79%, on 1,974,085 volume with 1,144 trades. The average volume for the last 3 months is 379,484 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST) has announced a partnership with Kevin Harrington’s ‘As Seen On TV’ production company for a Direct response media campaign (http://nnw.fm/T6tCX).

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.55, up 23.26%, on 302,215 volume with 305 trades. The average volume for the last 3 months is 46,838 and the stock's 52-week low/high is $0.421/$1.64.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Oil and gas company Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is on the verge of putting its oil on the market as it approaches 1,000 barrel per day capacity at its Asphalt Ridge oil sands extraction facility in Utah, according to the company president Dr. R. Gerald Bailey in a recent Uptick Newswire interview (http://nnw.fm/dD73M).

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.97, up 7.78%, on 207,885 volume with 134 trades. The average volume for the last 3 months is 423,131 and the stock's 52-week low/high is $0.289/$1.889.

Recent News

chart

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (BKKSF).

BLOCKSTRAIN TECHNOLOGY CORP. (TSXV: DNAX.V) (OTC: BKKSF) is pleased to announce that, effective as of September 28, 2018, the Company has appointed Swapan Kakumanu as Chief Financial Officer and a Director of the Company.

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (BKKSF), closed the day's trading session at $0.27, up 4.13%, on 67,608 volume with 26 trades. The average volume for the last 3 months is 111,727 and the stock's 52-week low/high is $0.109/$0.85.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) was highlighted today in an article by CannabisNewsWire. New data that has just been released by the U.S. Federal Bureau of Investigations (FBI) reveals that the marijuana arrests made in 2017 were more than those which were recorded in 2016. These statistics are surprising given the fact that, by the end of 2017, 28 states had legalized medical or recreational consumption of cannabis.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.211, up 2.94%, on 94,960 volume with 29 trades. The average volume for the last 3 months is 44,087 and the stock's 52-week low/high is $0.10/$0.8736.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

The cruise industry is big business, so it’s not surprising that the perceptive marketing practitioners at Youngevity International, Inc. (NASDAQ: YGYI) have spotted the commercial opportunities therein. The company recently announced that it had expanded its footprint in the cruise line industry by adding one more prestigious brand to its hospitality business (http://nnw.fm/B9vmt).

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $7.11, up 5.65%, on 186,949 volume with 839 trades. The average volume for the last 3 months is 49,638 and the stock's 52-week low/high is $3.1674/$7.75.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is focused on discovering new technologies that deliver cannabinoids and other lipophilic (fat soluble) beneficial molecules to the bloodstream through efficient and healthy ingestion. The first step to discovering how to deliver a higher percentage into the human bloodstream was to find a way to protect the molecules on their journey through the gastrointestinal system.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.94, up 1.57%, on 134,755 volume with 242 trades. The average volume for the last 3 months is 202,890 and the stock's 52-week low/high is $0.322/$2.539.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) is a clinical-stage biotechnology company based in Berkeley, California. The company is in the process of developing off-the-shelf personalized cancer treatment options, targeting advanced breast cancer patients.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0993, even for the day. The average volume for the last 3 months is 14,176 and the stock's 52-week low/high is $0.068/$0.1387.

Recent News

chart

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (OTCQB: ZNGY), the nation's leading next-generation utility, announced today that it has finalized the name change of its newly-acquired Texas-based Retail Electric Provider from Enertrade Electric, LLC DBA Shyne Energy to Zenergy Power & Gas, Inc. with the Public Utility Commission of Texas (PUCT).

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0004, even for the day, on 44,101,577 volume with 55 trades. The average volume for the last 3 months is 19,038,852 and the stock's 52-week low/high is $0.0004/$0.029.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW) announced it hired Kenneth S. Cragun to fill the new position of Chief Accounting Officer. Cragun will report to the Company’s CFO, William B. Horne. Cragun stated, “With its current portfolio, DPW has significant opportunities to drive growth and create value. And, with a strong financial infrastructure, we can leverage our foundation and expand our reach with additional investments. I am excited to partner with the team to drive long-term shareholder value.”

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.415, off by 0.84%, on 522,663 volume with 1,188 trades. The average volume for the last 3 months is 1,753,825 and the stock's 52-week low/high is $0.389/$5.95.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (OTCQB: PBIO) (the “Company”) President and CEO, Richard T. Schumacher, joined Stock Day’s Everett Jolly to discuss an exciting new instrument release, the recent featuring of their product line at the largest annual food science meeting in the world, and the continued development of their innovative and enabling Ultra Shear Technology (“UST”) platform. To hear all of Mr. Schumacher’s interview with Stock Day, please go here: http://nnw.fm/tBI8J.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $0.3299, off by 0.46%, on 1,263 volume with 8 trades. The average volume for the last 3 months is 1,901 and the stock's 52-week low/high is $2.70/$5.00.

Recent News

chart

GTX Corp (GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO).

GTX Corp (OTCBB: GTXO) (“the Company”), an Internet of Things (IoT) solutions provider in the GPS wearable location and wandering assistive technology business, announced today the launch of its new GPS tracker and Near Field Communication (NFC) digital ID system Rover Tracker.

GTX Corp (GTXO), a For Profit For Purpose company, designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business. Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (http://nnw.fm/mrcV2), there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • P.E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXO), closed the day's trading session at $0.031, off by 19.69%, on 183,218 volume with 14 trades. The average volume for the last 3 months is 1,653,399 and the stock's 52-week low/high is $0.0309/$0.4875.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTCMKTS: DVLP), an emerging leader in the cannabidiol (CBD) products marketplace providing business services and products supporting the cannabis industry including an online retail business for cannabidiol (CBD), hemp oil and health/wellness related products, announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada is set to legalize recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset,?WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0301, off by 5.35%, on 1,647,680 volume with 89 trades. The average volume for the last 3 months is 441,527 and the stock's 52-week low/high is $0.0125/$0.14.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the "Underwriters") pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 10,950,000 units (the "Units") at a price of $6.85 per Unit (the "Offering Price") for aggregate gross proceeds to the Company of $75,007,500 (the "Offering").

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $5.2387, off by 5.81%, on 1,409,572 volume with 3,440 trades. The average volume for the last 3 months is 851,744 and the stock's 52-week low/high is $2.784/$7.893.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.